Flavin Financial Services’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$258K Sell
2,989
-173
-5% -$15.2K 0.14% 75
2026
Q2
$247K Buy
3,162
+4
+0.1% +$323 0.14% 77
2026
Q1
$274K Sell
3,158
-16
-0.5% -$1.53K 0.18% 67
2025
Q4
$305K Sell
3,174
-677
-18% -$65.8K 0.21% 65
2025
Q3
$367K Sell
3,851
-5
-0.1% -$460 0.26% 60
2025
Q2
$336K Sell
3,856
-266
-6% -$22.6K 0.33% 60
2025
Q1
$370K Buy
4,122
+70
+2% +$6.26K 0.34% 60
2024
Q4
$324K Buy
+4,052
New +$351K 0.31% 60

Other funds holding MDT

Flavin Financial Services's MDT Position: Q3 2026 in Review

Flavin Financial Services reduced its Medtronic (MDT) stake by 5.5% in Q3 2026, selling an estimated $15.2K and leaving 2,989 shares worth $258K. The position accounts for 0.14% of the portfolio, ranked #75.

Flavin Financial Services first reported a position in MDT in Q4 2024 and has held it in 8 quarters since. The position peaked at $370K in Q1 2025. 987 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Flavin Financial Services held 2,989 shares of Medtronic worth $258K as of Q3 2026.
  • Flavin Financial Services sold 173 Medtronic shares in Q3 2026, an estimated $15.2K.
  • Medtronic made up 0.14% of Flavin Financial Services's portfolio in Q3 2026, its #75 holding.
  • Flavin Financial Services first reported a position in Medtronic in Q4 2024 and has held it in 8 quarters since.
  • Flavin Financial Services's Medtronic position peaked at $370K in Q1 2025.
  • 987 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Flavin Financial Services's 13F filing for Q3 2026, filed 21 Oct 2026.